Literature DB >> 8110689

In search of intraocular antibody production to parvo B19 virus and adenovirus in intermediate uveitis.

J H De Boer, R J De Keizer, A Kijlstra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8110689      PMCID： PMC504675          DOI： 10.1136/bjo.77.12.829

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  4 in total

1.  Measles virus antibody in aqueous humour of patients with uveitis associated with multiple sclerosis.

Authors:  E Bloch-Michel; L Helleboid; C Hill; S Koscielny; E Dussaix
Journal:  Lancet       Date:  1992-03-21       Impact factor: 79.321

Review 2.  Parvovirus B19 and human disease.

Authors:  T J Török
Journal:  Adv Intern Med       Date:  1992

Review 3.  Diagnostic vitrectomy in intermediate uveitis.

Authors:  J L Davis; C C Chan; R B Nussenblatt
Journal:  Dev Ophthalmol       Date:  1992

4.  Tonic pupils and human parvovirus (B19) infection.

Authors:  P G Corridan; D E Laws; A J Morrell; P I Murray
Journal:  J Clin Neuroophthalmol       Date:  1991-06
  4 in total
  4 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

Review 2.  Analysis of ocular fluids for local antibody production in uveitis.

Authors:  J H de Boer; L Luyendijk; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

3.  Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.

Authors:  Carsten Heinz; Annelie Plentz; Dirk Bauer; Arnd Heiligenhaus; Susanne Modrow
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

4.  Serous retinal detachment in a patient with aplastic anemia associated with parvovirus B19 infection.

Authors:  Jun Suzuki; Hiroshi Goto; Masahiko Usui; Jun-ichi Sakai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.